Immediate effect of orthotic therapy for patients with peripheral artery disease with intermittent claudicatio
Not Applicable
Recruiting
- Conditions
- Peripheral arterial diseae
- Registration Number
- JPRN-UMIN000034197
- Lead Sponsor
- Tohoku University Graduate School of Medicine Department of Internal Medicine and Rehabilitation Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with critical limb ischemia. Patients with limitations to walking for reasons other than claudication such as pulmonary, cardiac, nervous, and musculoskeletal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum walking distance in the 6-minutes walking test
- Secondary Outcome Measures
Name Time Method Walking speed Joint torque Joint power
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie orthotic therapy's impact on peripheral artery disease hemodynamics and muscle metabolism in intermittent claudication?
How does orthotic therapy compare to supervised exercise or cilostazol in improving walking distance for PAD patients with intermittent claudication?
Which biomarkers predict response to orthotic intervention in PAD with intermittent claudication, such as ankle-brachial index or inflammatory markers?
What are the potential adverse events of orthotic therapy in PAD patients, and what management strategies are recommended for mechanical complications?
What combination approaches with vascular-targeted devices or physical therapy enhance orthotic therapy outcomes in PAD with intermittent claudication?